At the dawn of the pandemic, the European Commission earmarked a large envelop to develop rapid health-related approaches to respond to the COVID-19 pandemic and to deliver quick results for society for a higher level of preparedness of health systems including medical supplies, equipment, technologies, socio-economic impact analysis of the outbreak. The COVIRNA project was a response to this objective by developing a CE-marked personalised diagnostic tool allowing the risk stratification of patients who will most likely be subject to fatal cardiovascular complication due to their COVID-19 infection. This novel approach allows health providers to improve clinical decision-making, adapt treatment, inform drug design and enable individualised surveillance, care and follow-up of COVID-19 patients.

After 30 months of collaboration, this Final Conference will present the achievements of the COVIRNA project. We will look at the database built with patients data and share learnings to facilitate the roll out of the RNA-based molecular research methodology in personalised diagnosis and therapy. In addition, the event will offer a platform to discuss what is needed for the product development of the COVIRNA toolkit and how it can be exploited for long-COVID or other (communicable) diseases.

We are pleased to welcome you on 19 April 2023 from 14:00 in Brussels to present you our achievements and progress.